GammaPod Registry and Quality of Life Nomogram
ConditionBreast Cancer Female
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity of Maryland, Baltimore
About this trial
This study is a prospective, single arm study (registry) summarizing patient-level adverse-event and tumor outcomes as well as a number of feasibility and dosimetric characteristics of delivering a single-fraction boost with the GammaPod.
Eligibility criteria
Qualifiers
The patient must sign consent for study participation.
The patient must be female and have a diagnosis of an invasive or non-invasive breast cancer that was treated surgically by a partial mastectomy.
The patient must be deemed an appropriate candidate for breast conserving therapy (i.e. not pregnant, never had radiation to the treated breast, breast size would allow adequate cosmesis after volume loss from partial mastectomy).
Patients with involved lymph nodes are candidates for the study.
Disqualifiers
Patients with proven multi-centric carcinoma (tumors in different quadrants of the breast or tumor separated by at least 4 cm).
Prior radiation therapy to that breast or that hemi thorax.
Unable to fit into the immobilization breast cup with an adequate seal.
Male gender.
Trial design
Treatments tested in this trial
- Quality Of Life Sizing Nomogram
Treatment groups
160 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Maryland, Baltimore
Lead sponsor
University of Texas, Southwestern Medical Center at Dallas
Collaborator
Source ClinicalTrials.gov